2019
DOI: 10.29328/journal.jsctt.1001017
|View full text |Cite
|
Sign up to set email alerts
|

Natural killer cells in patients with hematologic malignancies, solid tumors and in recipients of hematopoietic stem cell transplantation

Abstract: How to cite this article: Al-Anazi KA, Al-Jasser AM, Al-Anazi WK. Natural killer cells in patients with hematologic malignancies, solid tumors and in recipients of hematopoietic stem cell transplantation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 272 publications
(455 reference statements)
0
1
0
Order By: Relevance
“…Allogeneic or syngeneic NK cells are currently considered as effective agents to fight hematological tumors. The infusion of large numbers of expanded NK cells has been shown to be feasible and safe for enhancing their activity in preclinical studies and also in vivo for patients with different types of hematological tumors [ 13 , 14 , 15 ].…”
Section: Nk Cells In Cancer Pathogenesismentioning
confidence: 99%
“…Allogeneic or syngeneic NK cells are currently considered as effective agents to fight hematological tumors. The infusion of large numbers of expanded NK cells has been shown to be feasible and safe for enhancing their activity in preclinical studies and also in vivo for patients with different types of hematological tumors [ 13 , 14 , 15 ].…”
Section: Nk Cells In Cancer Pathogenesismentioning
confidence: 99%